Scarica l'app Stockscreener
176.55
0.62%
-1.10
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ILMN Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$177.65
Aprire:
$176.065
Volume 24 ore:
2.19M
Relative Volume:
1.28
Capitalizzazione di mercato:
$26.71B
Reddito:
$4.39B
Utile/perdita netta:
$853.00M
Rapporto P/E:
32.04
EPS:
5.5097
Flusso di cassa netto:
$556.00M
1 W Prestazione:
+9.03%
1M Prestazione:
+21.57%
6M Prestazione:
+30.83%
1 anno Prestazione:
+87.50%
Intervallo 1D:
$173.24
$179.93
Intervallo di 1 settimana:
$158.91
$182.84
Portata 52W:
$88.00
$182.84
Illumina Inc Stock (ILMN) Company Profile
Nome
Illumina Inc
Settore
Industria
Telefono
(858) 202-4500
Indirizzo
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN vs TMO, DHR, IDXX, A, NTRA
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
176.55 | 26.88B | 4.39B | 853.00M | 556.00M | 5.5097 |
TMO
Thermo Fisher Scientific Inc
|
513.03 | 187.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.19 | 136.75B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
551.50 | 43.78B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
136.01 | 38.27B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
261.91 | 37.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-12 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | Reiterato | Citigroup | Neutral |
| 2025-02-28 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-02-10 | Downgrade | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-11-12 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-08-28 | Aggiornamento | Argus | Hold → Buy |
| 2024-08-16 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-01-16 | Downgrade | HSBC Securities | Buy → Hold |
| 2024-01-04 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-11-10 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Iniziato | Bernstein | Underperform |
| 2023-07-05 | Ripresa | JP Morgan | Neutral |
| 2023-01-25 | Downgrade | Argus | Buy → Hold |
| 2023-01-05 | Iniziato | Scotiabank | Sector Perform |
| 2022-12-12 | Downgrade | Citigroup | Neutral → Sell |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-04 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-07-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Aggiornamento | Stifel | Hold → Buy |
| 2022-01-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Iniziato | Barclays | Underweight |
| 2020-12-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-10-13 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Downgrade | Stifel | Buy → Hold |
| 2020-09-22 | Downgrade | UBS | Buy → Neutral |
| 2020-09-21 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-09-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-24 | Downgrade | Citigroup | Buy → Neutral |
| 2020-04-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-10-25 | Iniziato | Guggenheim | Buy |
Mostra tutto
Illumina Inc Borsa (ILMN) Ultime notizie
Illumina at a fresh 52-week high, Bernstein SocGen resumes coverage on the shares - Ad-hoc-news.de
Illumina, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.2 Sh Actuals & Estimates (BMFBOVESPA:I1LM34) - TradingView
Laboratory Information Management Systems (LIMS) Market Size Expected to Reach USD 5.19 Billion by 2030 | MarketsandMarkets™ - GlobeNewswire Inc.
Illumina Stock Is Up 32% in 2026: Has the GRAIL Recovery Already Been Priced In? - TIKR.com
Bernstein SocGen resumes Illumina stock coverage with market perform rating - Investing.com
Illumina chief legal officer sells shares, stock trades near 52-week high - Ad-hoc-news.de
Illumina, Inc. Actuals & Estimates (HAN:ILU) - TradingView
Illumina chief legal officer sells $110,700 in company stock By Investing.com - Investing.com India
Insider Sell: Scott Davies Sells Shares of Illumina Inc (ILMN) - GuruFocus
Form 4 Illumina Inc For: 25 June By Investing.com - Investing.com Nigeria
Illumina (NASDAQ: ILMN) legal chief sells 615 shares in open-market trade - Stock Titan
Form 144 Illumina For: 25 June By Investing.com - Investing.com South Africa
Form 144 ILLUMINA For: 25 June By Investing.com - Investing.com Nigeria
Illumina, Inc. Actuals & Estimates (SIX:ILMN.USD) - TradingView
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina (NASDAQ: ILMN) affiliate files Form 144 reporting 98,400-share 10b5-1 sale - Stock Titan
Frances Arnold sells Illumina shares (ILMN) in multiple May–June 2026 trades - Stock Titan
Illumina welcomes Eli Lilly executive, shares react to Barclays target lift - Ad-hoc-news.de
Illumina Inc (ILMN) Stock Up 6.1% but GF Value Says Overvalued -- GF Score: 76/100 - GuruFocus
Why Illumina (ILMN) Stock Is Trading Up Today - Yahoo Finance
Chasing challenges & transforming global health - Illumina
Illumina Jumps 7.7% Amid Sector-Wide Rally - AlphaStreet
Illumina stock hits 52-week high at 177.76 USD By Investing.com - Investing.com Australia
Illumina stock hits 52-week high at 177.76 USD - Investing.com
Illumina (ILMN) Stock After 80% One-Year Rebound Is The Price Now Justified - Yahoo Finance
How Investors May Respond To Illumina (ILMN) Adding Eli Lilly R&D Chief To Its Board - simplywall.st
Form 4 Illumina Inc For: 23 June By Investing.com - Investing.com South Africa
(ILMN) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Adding Eli Lilly’s R&D Chief to the Board Might Change The Case For Investing In Illumina (ILMN) - Yahoo Finance
Illumina (ILMN) director Daniel Skovronsky files initial insider Form 3 - Stock Titan
Illumina (ILMN) director Daniel Skovronsky receives 1,674-share RSU grant - Stock Titan
Form 8K Illumina Inc For: 23 June By Investing.com - Investing.com Australia
Illumina, Inc. Announces Appointment of Daniel M. Skovronsky to Board of Directors, Effective June 16, 2026 - marketscreener.com
Illumina adds Eli Lilly executive to board of directors - Investing.com
Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors - Finviz
Illumina adds Daniel M. Skovronsky to its Board - TradingView
Illumina (NASDAQ: ILMN) appoints Eli Lilly R&D leader to its board - Stock Titan
Illumina adjusts analyst expectations, shares trade on rich valuation - AD HOC NEWS
The DRAGEN v4.3 from Illumina Inc.new pipelines push clinical sequencing speed - Ad-hoc-news.de
IQM Quantum Computers Appoints Former Illumina VP Craig Ciesla as CTO Ahead of Nasdaq Listing Through Merger with RAAQ – Minichart - Minichart
Illumina, Inc. (ILMN) Stock Analysis: Navigating Growth in Genomic Innovation with a 4.8% Revenue Surge - DirectorsTalk Interviews
Illumina Inc (ILMN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Illumina StockLong-term strategy in focus after Grail divestiture - Ad-hoc-news.de
IQM nomme Craig Ciesla, ancien vice-président d’Illumina, au poste de directeur technique ; Inés de Vega devient directrice scientifique - Eagle-Tribune
Why Illumina’s NovaSeq X Plus is quietly reshaping high-throughput genomics - AD HOC NEWS
IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist - Business Wire
Video: Professor Emma Baple on bringing whole-genome sequencing into clinical research - Illumina
Illumina Inc (ILMN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Illumina Inc (ILMN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Illumina Inc (ILMN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Illumina Inc (ILMN) Shares Fall 3.2% -- GF Value Says Still Over - GuruFocus
Illumina Inc Azioni (ILMN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.64%
0.66%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):